IP Library Granted Patent US 11,116,911
Granted Patent B2
US 11,116,911 · App. 15/484,642 · Granted Sep 14, 2021

Injector lockout prevention device

Inventor: Haiming Wu (Weston, MA)
Assignee: BIOGEN MA, INC.
A61M5/3204A61M5/2033A61M5/31578A61M5/326A61M2005/2073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,911
App. No.
15/484,642
Granted
Sep 14, 2021
Kind
B2
Abstract

A device that prevents the accidental activation and lockout of an autoinjector. In illustrative embodiments, a resistance unit is configured to resist deployment of the needle until a critical force is applied by the user to the autoinjector, at which point, the resistance of the resistance unit is overcome. Continuous application of force by the user after the resistance is overcome drives the delivery device to the injection site where the medication is administered.

Claims (13)

1. An autoinjector, comprising:

a housing having a proximal end and a distal end;

a delivery device disposed within, and moveable relative to, the housing, wherein the delivery device comprises a syringe;

a needle guard at the distal end of the housing, the needle guard being coupled to the syringe and configured to move the syringe through the housing to an injection site; and

a resistance unit having a proximal end and a distal end, the entire proximal end of the resistance unit being disposed within the needle guard,

the resistance unit comprising a ring and a base;

the ring comprising at least one protrusion; and

the base comprising an annular end wall, a skirt extending from the annular end wall, and cantilever arms extending from the skirt, the cantilever arms comprising at least one recess configured to receive the at least one protrusion; and

the resistance unit being configured to have a first position, wherein the cantilevered arms receive the at least one protrusion such that the resistance unit prevents the needle guard from exposing the syringe to the injection site, and a second position, wherein the resistance unit does not prevent the needle guard from exposing the syringe to the injection site;

wherein an injection force, required to expose the syringe to the injection site, is transmitted by application of a critical force to the autoinjector, which is required to move the resistance unit from the first position to the second position.

2. The autoinjector of claim 1 , wherein movement of the resistance unit from the first position into the second position, by applying a critical force to the autoinjector, is configured to release the at least one protrusion from the cantilevered arms.

3. The autoinjector of claim 1 , wherein, in the second position, application of the injection force to the autoinjector is configured to cause the needle guard to expose the syringe to the injection site; and wherein the injection force is less than the critical force.

4. The autoinjector of claim 1 , wherein the autoinjector further comprises an end cap for selectively covering the distal end of the housing and the needle guard.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: WU, HAIMING
To: BIOGEN MA INC.
Reel/Frame 049281/0012 →
Continuity (2)
Provisional Application 62321052 · Apr 11, 2016
Related Publication 20170290990A1 · Oct 12, 2017
Cited By (6)
US 12,268,858 US 12,274,873 US 12,274,874 US 12,337,159 US 12,521,495 US 12,527,919